IL-6 as a keystone cytokine in health and disease (original) (raw)

• Schett, G., Elewaut, D., McInnes, I.B., Dayer, J.M. & Neurath, M.F. How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy. Nat. Med. 19, 822–824 (2013).
  Article CAS PubMed Google Scholar
• Choy, E.H., Kavanaugh, A.F. & Jones, S.A. The problem of choice: current biologic agents and future prospects in RA. Nat. Rev. Rheumatol. 9, 154–163 (2013).
  CAS Google Scholar
• Hueber, W. et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 61, 1693–1700 (2012).
  Article CAS PubMed Google Scholar
• McInnes, I.B. & Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7, 429–442 (2007).
  Article CAS PubMed Google Scholar
• Jones, S.A., Scheller, J. & Rose-John, S. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J. Clin. Invest. 121, 3375–3383 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Tanaka, Y. & Martin Mola, E. IL-6 targeting compared to TNF targeting in rheumatoid arthritis: studies of olokizumab, sarilumab and sirukumab. Ann. Rheum. Dis. 73, 1595–1597 (2014).
  Article CAS PubMed Google Scholar
• Yasukawa, K. et al. Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J. 6, 2939–2945 (1987).
  Article CAS PubMed PubMed Central Google Scholar
• Woloski, B.M. & Fuller, G.M. Identification and partial characterization of hepatocyte-stimulating factor from leukemia cell lines: comparison with interleukin 1. Proc. Natl. Acad. Sci. USA 82, 1443–1447 (1985).
  Article CAS PubMed PubMed Central Google Scholar
• Klimpel, G.R. Soluble factor(s) from LPS-activated macrophages induce cytotoxic T cell differentiation from alloantigen-primed spleen cells. J. Immunol. 125, 1243–1249 (1980).
  CAS PubMed Google Scholar
• Yoshizaki, K. et al. Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line. J. Immunol. 132, 2948–2954 (1984).
  CAS PubMed Google Scholar
• Andus, T. et al. Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-beta 2) regulates beta-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett. 221, 18–22 (1987).
  Article CAS PubMed Google Scholar
• Hirano, T. et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324, 73–76 (1986).
  Article CAS PubMed Google Scholar
• Hirano, T. Revisiting the 1986 molecular cloning of interleukin 6. Front. Immunol. 5, 456 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Rohleder, N., Aringer, M. & Boentert, M. Role of interleukin-6 in stress, sleep, and fatigue. Ann. NY Acad. Sci. 1261, 88–96 (2012).
  Article CAS PubMed Google Scholar
• Bethin, K.E., Vogt, S.K. & Muglia, L.J. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc. Natl. Acad. Sci. USA 97, 9317–9322 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Hodes, G.E. et al. Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc. Natl. Acad. Sci. USA 111, 16136–16141 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Kraakman, M.J. et al. Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance. Cell Metab. 21, 403–416 (2015).
  Article CAS PubMed Google Scholar
• Masuda, K. et al. Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo. Proc. Natl. Acad. Sci. USA 110, 9409–9414 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Sarwar, N. et al. Clock gene Per1 regulates the production of CCL2 and interleukin-6 through p38, JNK1 and NF-κB activation in spinal astrocytes. Mol. Cell. Neurosci. 59, 37–46 (2014).
  Article CAS Google Scholar
• Viswanathan, S.R. et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat. Genet. 41, 843–848 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P. & Espevik, T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med. 169, 333–338 (1989).
  Article CAS PubMed Google Scholar
• Fraunberger, P. et al. Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever. Shock 26, 10–12 (2006).
  Article CAS PubMed Google Scholar
• Mroczko, B., Groblewska, M., Gryko, M., Kedra, B. & Szmitkowski, M. Diagnostic usefulness of serum interleukin 6 (IL-6) and C-reactive protein (CRP) in the differentiation between pancreatic cancer and chronic pancreatitis. J. Clin. Lab. Anal. 24, 256–261 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Panichi, V. et al. Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients. Nephrol. Dial. Transplant. 19, 1154–1160 (2004).
  Article CAS PubMed Google Scholar
• Dienz, O. et al. Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung. Mucosal Immunol. 5, 258–266 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Garbers, C. et al. Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor. J. Biol. Chem. 286, 42959–42970 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Hoge, J. et al. IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling. J. Immunol. 190, 703–711 (2013).
  Article CAS PubMed Google Scholar
• Kopf, M. et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339–342 (1994).
  Article CAS PubMed Google Scholar
• Longhi, M.P. et al. Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells. PLoS Pathog. 4, e1000006 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Neveu, W.A. et al. IL-6 is required for airway mucus production induced by inhaled fungal allergens. J. Immunol. 183, 1732–1738 (2009).
  Article CAS PubMed Google Scholar
• Smith, K.A. & Maizels, R.M. IL-6 controls susceptibility to helminth infection by impeding Th2 responsiveness and altering the Treg phenotype in vivo. Eur. J. Immunol. 44, 150–161 (2014).
  Article CAS PubMed Google Scholar
• van der Poll, T. et al. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J. Infect. Dis. 176, 439–444 (1997).
  Article CAS PubMed Google Scholar
• Puel, A. et al. Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6. J. Immunol. 180, 647–654 (2008).
  Article CAS PubMed Google Scholar
• Freeman, A.F. & Holland, S.M. Clinical manifestations of hyper IgE syndromes. Dis. Markers 29, 123–130 (2010).
  Article PubMed PubMed Central Google Scholar
• Gealy, C. et al. Posttranscriptional suppression of interleukin-6 production by human cytomegalovirus. J. Virol. 79, 472–485 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Fielding, C.A. et al. Viral IL-6 blocks neutrophil infiltration during acute inflammation. J. Immunol. 175, 4024–4029 (2005).
  Article CAS PubMed Google Scholar
• Moore, P.S., Boshoff, C., Weiss, R.A. & Chang, Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274, 1739–1744 (1996).
  Article CAS PubMed Google Scholar
• Chatterjee, M., Osborne, J., Bestetti, G., Chang, Y. & Moore, P.S. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298, 1432–1435 (2002).
  Article CAS PubMed Google Scholar
• Jones, K.D. et al. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood 94, 2871–2879 (1999).
  Article CAS PubMed Google Scholar
• Chang, Y. et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865–1869 (1994).
  Article CAS PubMed Google Scholar
• Eugster, H.P., Frei, K., Kopf, M., Lassmann, H. & Fontana, A. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28, 2178–2187 (1998).
  Article CAS PubMed Google Scholar
• Ohshima, S. et al. Interleukin-6 plays a key role in the development of antigen-induced arthritis. Proc. Natl. Acad. Sci. USA 95, 8222–8226 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Alonzi, T. et al. Interleukin 6 is required for the development of collagen-induced arthritis. J. Exp. Med. 187, 461–468 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Richards, H.B. et al. Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J. Exp. Med. 188, 985–990 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Lattanzio, G. et al. Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice. Am. J. Pathol. 151, 689–696 (1997).
  CAS PubMed PubMed Central Google Scholar
• Screpanti, I. et al. Inactivation of the IL6-gene prevents development of multicentric Castleman's disease in C/EBPβ-deficient mice. J. Exp. Med. 184, 1561–1566 (1996).
  Article CAS PubMed Google Scholar
• Suematsu, S. et al. IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. USA 86, 7547–7551 (1989).
  Article CAS PubMed PubMed Central Google Scholar
• Campbell, I.L. et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA 90, 10061–10065 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Steiner, M.K., Syrkina, O.L., Kolliputi, N., Mark, E.J., Hales, C.A. & Waxman, A.B. Interleukin-6 overexpression induces pulmonary hypertension. Circ. Res. 104, 236–244 (2009).
  Article CAS PubMed Google Scholar
• DiCosmo, B.F. et al. Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity. J. Clin. Invest. 94, 2028–2035 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Li, N., Grivennikov, S.I. & Karin, M. The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment. Cancer Cell 19, 429–431 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Rebouissou, S. et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 457, 200–204 (2009).
  Article CAS PubMed Google Scholar
• Collaboration, I.R.G.C.E.R.F. et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 379, 1205–1213 (2012).
• Deloukas, P. et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 45, 25–33 (2013).
  Article CAS PubMed Google Scholar
• Fishman, D. et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102, 1369–1376 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Stahl, E.A. et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 42, 508–514 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Hibi, M. et al. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63, 1149–1157 (1990).
  Article CAS PubMed Google Scholar
• Taga, T. et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58, 573–581 (1989).
  Article CAS PubMed Google Scholar
• Taga, T., Kawanishi, Y., Hardy, R.R., Hirano, T. & Kishimoto, T. Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression. J. Exp. Med. 166, 967–981 (1987).
  Article CAS PubMed Google Scholar
• Yamasaki, K. et al. Cloning and expression of the human interleukin-6 (BSF-2/IFNβ2) receptor. Science 241, 825–828 (1988).
  Article CAS PubMed Google Scholar
• Skiniotis, G., Boulanger, M.J., Garcia, K.C. & Walz, T. Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor. Nat. Struct. Mol. Biol. 12, 545–551 (2005).
  Article CAS PubMed Google Scholar
• Heinrich, P.C. et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374, 1–20 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Yoshida, K. et al. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA 93, 407–411 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Jones, G.W. et al. Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells. J. Immunol. 184, 2130–2139 (2010).
  Article CAS PubMed Google Scholar
• McFarland-Mancini, M.M. et al. Differences in wound healing in mice with deficiency of IL-6 versus IL-6 receptor. J. Immunol. 184, 7219–7228 (2010).
  Article CAS PubMed Google Scholar
• Mauer, J. et al. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat. Immunol. 15, 423–430 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Sommer, J. et al. Interleukin-6, but not the interleukin-6 receptor plays a role in recovery from dextran sodium sulfate-induced colitis. Int. J. Mol. Med. 34, 651–660 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Stumhofer, J.S. et al. A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat. Immunol. 11, 1119–1126 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Garbers, C. et al. An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer. J. Biol. Chem. 288, 4346–4354 (2013).
  Article CAS PubMed Google Scholar
• Crabé, S. et al. The IL-27 p28 subunit binds cytokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling. J. Immunol. 183, 7692–7702 (2009).
  Article CAS PubMed Google Scholar
• Schuster, B. et al. Signaling of human ciliary neurotrophic factor (CNTF) revisited. The interleukin-6 receptor can serve as an α-receptor for CTNF. J. Biol. Chem. 278, 9528–9535 (2003).
  Article CAS PubMed Google Scholar
• Yasukawa, H. et al. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat. Immunol. 4, 551–556 (2003).
  Article CAS PubMed Google Scholar
• Croker, B.A. et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 4, 540–545 (2003).
  Article CAS PubMed Google Scholar
• Atsumi, T. et al. A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis. J. Exp. Med. 196, 979–990 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Jenkins, B.J. et al. Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis. Blood 109, 2380–2388 (2007).
  Article CAS PubMed Google Scholar
• Jones, G.W. et al. Exacerbated inflammatory arthritis in response to hyperactive gp130 signalling is independent of IL-17A. Ann. Rheum. Dis. 72, 1738–1742 (2013).
  Article CAS PubMed Google Scholar
• Jones, G.W. et al. Imbalanced gp130 signalling in ApoE-deficient mice protects against atherosclerosis. Atherosclerosis 238, 321–328 (2015).
  Article CAS PubMed Google Scholar
• Nowell, M.A. et al. Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. J. Immunol. 182, 613–622 (2009).
  Article CAS PubMed Google Scholar
• Rose-John, S. & Heinrich, P.C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300, 281–290 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Peters, M. et al. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J. Exp. Med. 183, 1399–1406 (1996).
  Article CAS PubMed Google Scholar
• Gearing, D.P. & Cosman, D. Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor. Cell 66, 9–10 (1991).
  Article CAS PubMed Google Scholar
• Schobitz, B. et al. Soluble interleukin-6 (IL-6) receptor augments central effects of IL-6 in vivo. FASEB J. 9, 659–664 (1995).
  Article CAS PubMed Google Scholar
• Jones, S.A. Directing transition from innate to acquired immunity: defining a role for IL-6. J. Immunol. 175, 3463–3468 (2005).
  Article CAS PubMed Google Scholar
• Campbell, I.L. et al. Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain. J. Neurosci. 34, 2503–2513 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Atreya, R. et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat. Med. 6, 583–588 (2000).
  Article CAS PubMed Google Scholar
• Briso, E.M., Dienz, O. & Rincon, M. Cutting edge: soluble IL-6R is produced by IL-6R ectodomain shedding in activated CD4 T cells. J. Immunol. 180, 7102–7106 (2008).
  Article CAS PubMed Google Scholar
• Modur, V., Li, Y., Zimmerman, G.A., Prescott, S.M. & McIntyre, T.M. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor α. J. Clin. Invest. 100, 2752–2756 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• McLoughlin, R.M. et al. Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms. J. Immunol. 172, 5676–5683 (2004).
  Article CAS PubMed Google Scholar
• Hurst, S.M. et al. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14, 705–714 (2001).
  Article CAS PubMed Google Scholar
• Jones, S.A. et al. C-reactive protein: a physiological activator of interleukin 6 receptor shedding. J. Exp. Med. 189, 599–604 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Marin, V. et al. The IL-6-soluble IL-6Rα autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin. J. Immunol. 167, 3435–3442 (2001).
  Article CAS PubMed Google Scholar
• Marin, V. et al. Chemotactic agents induce IL-6Rα shedding from polymorphonuclear cells: involvement of a metalloproteinase of the TNF-α-converting enzyme (TACE) type. Eur. J. Immunol. 32, 2965–2970 (2002).
  Article CAS PubMed Google Scholar
• Liao, W., Lin, J.X., Wang, L., Li, P. & Leonard, W.J. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat. Immunol. 12, 551–559 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Curnow, S.J. et al. Inhibition of T cell apoptosis in the aqueous humor of patients with uveitis by IL-6/soluble IL-6 receptor trans-signaling. J. Immunol. 173, 5290–5297 (2004).
  Article CAS PubMed Google Scholar
• Jones, S.A., Horiuchi, S., Topley, N., Yamamoto, N. & Fuller, G.M. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J. 15, 43–58 (2001).
  Article CAS PubMed Google Scholar
• Novick, D., Engelmann, H., Wallach, D. & Rubinstein, M. Soluble cytokine receptors are present in normal human urine. J. Exp. Med. 170, 1409–1414 (1989).
  Article CAS PubMed Google Scholar
• Honda, M. et al. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J. Immunol. 148, 2175–2180 (1992).
  CAS PubMed Google Scholar
• Baran, P., Nitz, R., Grotzinger, J., Scheller, J. & Garbers, C. Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling. J. Biol. Chem. 288, 14756–14768 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Garbers, C. et al. Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding. J. Biol. Chem. 286, 14804–14811 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Rose-John, S. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int. J. Biol. Sci. 8, 1237–1247 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Garbers, C. et al. The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases. Biochim. Biophys. Acta 1842, 1485–1494 (2014).
  Article CAS PubMed Google Scholar
• Esteve, E. et al. Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome. Clin. Endocrinol. 65, 88–91 (2006).
  Article CAS Google Scholar
• Song, Y. et al. The interaction between the interleukin 6 receptor gene genotype and dietary energy intake on abdominal obesity in Japanese men. Metabolism 56, 925–930 (2007).
  Article CAS PubMed Google Scholar
• Lin, M., Rose-John, S., Grotzinger, J., Conrad, U. & Scheller, J. Functional expression of a biologically active fragment of soluble gp130 as an ELP-fusion protein in transgenic plants: purification via inverse transition cycling. Biochem. J. 398, 577–583 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, Y., Horiuchi, S., Yamamoto, M. & Yamamoto, N. Elevated serum levels of the soluble form of gp130, the IL-6 signal transducer, in HTLV-1 infection and no involvement of alternative splicing for its generation. Microbiol. Immunol. 42, 109–116 (1998).
  Article CAS PubMed Google Scholar
• Richards, P.J. et al. Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis. Arthritis Rheum. 54, 1662–1672 (2006).
  Article CAS PubMed Google Scholar
• Tanaka, M. et al. Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis. J. Clin. Invest. 106, 137–144 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Diamant, M. et al. Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130. FEBS Lett. 412, 379–384 (1997).
  Article CAS PubMed Google Scholar
• Sharkey, A.M. et al. Stage-specific expression of cytokine and receptor messenger ribonucleic acids in human preimplantation embryos. Biol. Reprod. 53, 974–981 (1995).
  Article CAS PubMed Google Scholar
• Jostock, T. et al. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur. J. Biochem. 268, 160–167 (2001).
  Article CAS PubMed Google Scholar
• Müller-Newen, G. et al. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. J. Immunol. 161, 6347–6355 (1998).
  PubMed Google Scholar
• Narazaki, M. et al. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood 82, 1120–1126 (1993).
  Article CAS PubMed Google Scholar
• Hombría, J.C., Brown, S., Hader, S. & Zeidler, M.P. Characterisation of Upd2, a Drosophila JAK/STAT pathway ligand. Dev. Biol. 288, 420–433 (2005).
  Article CAS PubMed Google Scholar
• Brown, S., Hu, N. & Hombria, J.C. Identification of the first invertebrate interleukin JAK/STAT receptor, the Drosophila gene domeless. Curr. Biol. 11, 1700–1705 (2001).
  Article CAS PubMed Google Scholar
• Kingsolver, M.B. & Hardy, R.W. Making connections in insect innate immunity. Proc. Natl. Acad. Sci. USA 109, 18639–18640 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Woodcock, K.J. et al. Macrophage-derived upd3 cytokine causes impaired glucose homeostasis and reduced lifespan in Drosophila fed a lipid-rich diet. Immunity 42, 133–144 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Greenhill, C.J. et al. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3. J. Immunol. 186, 1199–1208 (2011).
  Article CAS PubMed Google Scholar
• Silver, J.S., Stumhofer, J.S., Passos, S., Ernst, M. & Hunter, C.A. IL-6 mediates the susceptibility of glycoprotein 130 hypermorphs to Toxoplasma gondii. J. Immunol. 187, 350–360 (2011).
  Article CAS PubMed Google Scholar
• Chou, D.B. et al. Stromal-derived IL-6 alters the balance of myeloerythroid progenitors during Toxoplasma gondii infection. J. Leukoc. Biol. 92, 123–131 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, F., Poursine-Laurent, J., Wu, H.Y. & Link, D.C. Interleukin-6 and the granulocyte colony-stimulating factor receptor are major independent regulators of granulopoiesis in vivo but are not required for lineage commitment or terminal differentiation. Blood 90, 2583–2590 (1997).
  Article CAS PubMed Google Scholar
• Chen, Q. et al. Central role of IL-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stress. Immunity 20, 59–70 (2004).
  Article CAS PubMed Google Scholar
• Romano, M. et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6, 315–325 (1997).
  Article CAS PubMed Google Scholar
• Matsumiya, T. et al. Soluble interleukin-6 receptor α inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture. Exp. Cell Res. 269, 35–41 (2001).
  Article CAS PubMed Google Scholar
• Chalaris, A. et al. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood 110, 1748–1755 (2007).
  Article CAS PubMed Google Scholar
• McLoughlin, R.M. et al. Interplay between IFN-γ and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J. Clin. Invest. 112, 598–607 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Xing, Z. et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101, 311–320 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Lauder, S.N. et al. Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology. Eur. J. Immunol. 43, 2613–2625 (2013).
  Article CAS PubMed Google Scholar
• Lally, F. et al. A novel mechanism of neutrophil recruitment in a coculture model of the rheumatoid synovium. Arthritis Rheum. 52, 3460–3469 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Chomarat, P., Banchereau, J., Davoust, J. & Palucka, A.K. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol. 1, 510–514 (2000).
  Article CAS PubMed Google Scholar
• Bleier, J.I., Pillarisetty, V.G., Shah, A.B. & DeMatteo, R.P. Increased and long-term generation of dendritic cells with reduced function from IL-6-deficient bone marrow. J. Immunol. 172, 7408–7416 (2004).
  Article CAS PubMed Google Scholar
• Jenkins, B.J. et al. Imbalanced gp130-dependent signaling in macrophages alters macrophage colony-stimulating factor responsiveness via regulation of c-fms expression. Mol. Cell. Biol. 24, 1453–1463 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Hegde, S., Pahne, J. & Smola-Hess, S. Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-κB binding activity and CCR7 expression. FASEB J. 18(12): 1439–1441 (2004).
  Article CAS PubMed Google Scholar
• Tilg, H., Trehu, E., Atkins, M.B., Dinarello, C.A. & Mier, J.W. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83, 113–118 (1994).
  Article CAS PubMed Google Scholar
• Beaman, M.H., Hunter, C.A. & Remington, J.S. Enhancement of intracellular replication of Toxoplasma gondii by IL-6. Interactions with IFN-γ and TNF-α. J. Immunol. 153, 4583–4587 (1994).
  CAS PubMed Google Scholar
• Nagabhushanam, V. et al. Innate inhibition of adaptive immunity: _mycobacterium tuberculosis_-induced IL-6 inhibits macrophage responses to IFN-γ. J. Immunol. 171, 4750–4757 (2003).
  Article CAS PubMed Google Scholar
• Yoshizaki, K. et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74, 1360–1367 (1989).
  Article CAS PubMed Google Scholar
• Nishimoto, N. et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 95, 56–61 (2000).
  Article CAS PubMed Google Scholar
• Rosser, E.C. et al. Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production. Nat. Med. 20, 1334–1339 (2014).
  Article CAS PubMed Google Scholar
• Barr, T.A. et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J. Exp. Med. 209, 1001–1010 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Barr, T.A., Brown, S., Mastroeni, P. & Gray, D. TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica. J. Immunol. 185, 2783–2789 (2010).
  Article CAS PubMed Google Scholar
• Ma, C.S., Deenick, E.K., Batten, M. & Tangye, S.G. The origins, function, and regulation of T follicular helper cells. J. Exp. Med. 209, 1241–1253 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Nurieva, R.I. et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29, 138–149 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Dienz, O. et al. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J. Exp. Med. 206, 69–78 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Harker, J.A., Lewis, G.M., Mack, L. & Zuniga, E.I. Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection. Science 334, 825–829 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Rincón, M., Anguita, J., Nakamura, T., Fikrig, E. & Flavell, R.A. Interleukin(IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J. Exp. Med. 185, 461–469 (1997).
  Article PubMed PubMed Central Google Scholar
• Fielding, C.A. et al. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity 40, 40–50 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Veldhoen, M., Hocking, R.J., Atkins, C.J., Locksley, R.M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179–189 (2006).
  Article CAS PubMed Google Scholar
• Harrington, L.E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123–1132 (2005).
  Article CAS PubMed Google Scholar
• Zhou, L. et al. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967–974 (2007).
  Article CAS PubMed Google Scholar
• Acosta-Rodriguez, E.V., Napolitani, G., Lanzavecchia, A. & Sallusto, F. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8, 942–949 (2007).
  Article CAS PubMed Google Scholar
• Korn, T. et al. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature 448, 484–487 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Veldhoen, M. et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106–109 (2008).
  Article CAS PubMed Google Scholar
• Ivanov, I.I. et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121–1133 (2006).
  Article CAS PubMed Google Scholar
• Stumhofer, J.S. et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7, 937–945 (2006).
  Article CAS PubMed Google Scholar
• Iwakura, Y., Ishigame, H., Saijo, S. & Nakae, S. Functional specialization of interleukin-17 family members. Immunity 34, 149–162 (2011).
  Article CAS PubMed Google Scholar
• Liu, L. et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208, 1635–1648 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Dileepan, T. et al. Robust antigen specific th17 T cell response to group A Streptococcus is dependent on IL-6 and intranasal route of infection. PLoS Pathog. 7, e1002252 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Stumhofer, J.S. et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8, 1363–1371 (2007).
  Article CAS PubMed Google Scholar
• McGeachy, M.J. et al. TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat. Immunol. 8, 1390–1397 (2007).
  Article CAS PubMed Google Scholar
• Korn, T. et al. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells. Proc. Natl. Acad. Sci. USA 105, 18460–18465 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Pasare, C. & Medzhitov, R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299, 1033–1036 (2003).
  Article CAS PubMed Google Scholar
• Fujimoto, M. et al. The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cells. J. Immunol. 186, 32–40 (2011).
  Article CAS PubMed Google Scholar
• Sharma, M.D. et al. An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos. Immunity 38, 998–1012 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Sharma, S. et al. T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses. Proc. Natl. Acad. Sci. USA 108, 19001–19006 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Wohlfert, E.A. et al. GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice. J. Clin. Invest. 121, 4503–4515 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• O'Connor, R.A., Floess, S., Huehn, J., Jones, S.A. & Anderton, S.M. Foxp3+ Treg cells in the inflamed CNS are insensitive to IL-6-driven IL-17 production. Eur. J. Immunol. 42, 1174–1179 (2012).
  Article CAS PubMed Google Scholar
• Chaudhry, A. et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326, 986–991 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Durant, L. et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 32, 605–615 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Klein, B., Lu, Z.Y., Gaillard, J.P., Harousseau, J.L. & Bataille, R. Inhibiting IL-6 in human multiple myeloma. Curr. Top. Microbiol. Immunol. 182, 237–244 (1992).
  CAS PubMed Google Scholar
• Lu, Z.Y. et al. High amounts of circulating interleukin (IL)-6 in the form of monomeric immune complexes during anti-IL-6 therapy. Towards a new methodology for measuring overall cytokine production in human in vivo. Eur. J. Immunol. 22, 2819–2824 (1992).
  Article CAS PubMed Google Scholar
• Sato, K. et al. Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. Cancer Res. 53, 851–856 (1993).
  CAS PubMed Google Scholar
• Schroers, A., Hecht, O., Kallen, K.J., Pachta, M., Rose-John, S., Grotzinger, J. Dynamics of the gp130 cytokine complex: a model for assembly on the cellular membrane. Protein Science 14, 783–790 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Varghese, J.N. et al. Structure of the extracellular domains of the human interleukin-6 receptor α-chain. Proc. Natl. Acad. Sci. USA 99, 15959–15964 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Shaw, S. et al. Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signaling. MAbs 6, 774–782 (2014).
  Article PubMed Google Scholar
• Genovese, M.C. et al. Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised phase IIb study. Ann. Rheum. Dis. 73, 1607–1615 (2014).
  Article CAS PubMed Google Scholar
• Lissilaa, R. et al. Although IL-6 trans-signaling is sufficient to drive local immune responses, classical IL-6 signaling is obligate for the induction of T cell-mediated autoimmunity. J. Immunol. 185, 5512–5521 (2010).
  Article CAS PubMed Google Scholar
• Barkhausen, T. et al. Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model. Crit. Care Med. 39, 1407–1413 (2011).
  Article CAS PubMed Google Scholar
• Grivennikov, S. et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15, 103–113 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Spehlmann, M.E. et al. Trp53 deficiency protects against acute intestinal inflammation. J. Immunol. 191, 837–847 (2013).
  Article CAS PubMed Google Scholar
• Navarini, A.A., French, L.E. & Hofbauer, G.F. Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection. J. Allergy Clin. Immunol. 128, 1128–1130 (2011).
  Article CAS PubMed Google Scholar
• Taniguchi, K. et al. A gp130-Src-YAP module links inflammation to epithelial regeneration. Nature 519, 57–62 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Pitzalis, C., Jones, G.W., Bombardieri, M. & Jones, S.A. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat. Rev. Immunol. 14, 447–462 (2014).
  Article CAS PubMed Google Scholar